Risk stratification for positive lymph nodes in prostate cancer

Journal of Endourology

Volumn 22, Issue 5, 2008, Pages 1021-1025

  Pettus, Joseph A ^a   Masterson, Timothy A ^a   Abel, E Jason ^a   Middleton, Richard G ^a   Stephenson, Robert A ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PELVIS LYMPH NODE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

BIOPSY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 43749090417     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.0129     Document Type: Article

References (21)

1. Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 2002;29:173.
2. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994;151:1315.
3. Joseph JV, Rosenbaum R, Madeb R, Erturk E, Patel HR. Robotic extraperitoneal radical prostatectomy: An alternative approach. J Urol 2006;175:945.
4. Menon M, Tewari A, Peabody J. Vattikuti Institute prostatectomy: Technique. J Urol 2003;169:2289.
5. Guillonneau B, el-Fettouh H, Baumert H, et al. Laparoscopic radical prostatectomy: Oncological evaluation after 1,000 cases a Montsouris Institute. J Urol 2003;169:126.
6. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843.
7. Blute ML, Bergstralh EJ, Partin AW, et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000;164:1591.
8. Rees MA, Resnick MI, Oesterling JE. Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer. Urol Clin North Am 1997;24:379.
9. El-Galley RE, Keane TE, Petros JA, et al. Evaluation of staging lymphadenectomy in prostate cancer. Urology 1998;52:663.
10. D'Amico AV, Whittington R, Malkowicz SB, et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 2001;166:2185.
11. Link RE, Morton RA. Indications for pelvic lymphadenectomy in prostate cancer. Urol Clin North Am 2001;28:491.
12. Hu JC, Nelson RA, Wilson TG, et al. Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy. J Urol 2006;175:541.
13. Tewari A, Menon M. Vattikuti Institute prostatectomy: Surgical technique and current results. Curr Urol Rep 2003;4:119.
14. El-Feel A, Davis JW, Deger S, et al. Laparoscopic radical prostatectomy - An analysis of factors affecting operating time. Urology 2003;62:314.
15. Menon M, Tewari A. Robotic radical prostatectomy and the Vattikuti Urology Institute technique: An interim analysis of results and technical points. Urology 2003;61:15.
16. Guillonneau B, Cappele O, Martinez JB, Navarra S, Vallancien G. Robotic assisted, laparoscopic pelvic lymph node dissection in humans. J Urol 2001;165:1078.
17. Rozet F, Galiano M, Cathelineau X, Barret E, Cathala N, Vallancien G. Extraperitoneal laparoscopic radical prostatectomy: A prospective evaluation of 600 cases. J Urol 2005;174:908.
18. Bishoff JI, Reyes A, Thompson IM, et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: Development of a system of patient selection. Urology 1995;45:270.
19. Beissner RS, Stricker JB, Speights VO, Coffield KS, Spiekerman AM, Riggs M. Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis. Urology 2002;59:721.
20. Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA. No difference in six-year biochemical failure rates with or without lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology 2004;63:528.
21. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003;169:849.